Transparency Market Research (TMR) has announced the addition of a new market study based on the vitreous tamponades market. The report analyzes the drivers and restraints of the vitreous tamponades market and the impact of these on the demand for vitreous tamponades during the forecast period from 2014 to 2020. The report studies the attractiveness of the vitreous tamponades market for investment on the basis of factors such as growth rate and market size. According to the report, the global vitreous tamponades market is expected to expand at a CAGR of 2.5% during the period from 2014 to 2020. The market, which was valued at US$64.5 bn in 2014, is expected to reach a value of US$77.5 bn by the end of 2020. The report is titled “Vitreous Tamponades Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020.” The report provides information that helps a reader have a clear and decisive opinion on the vitreous tamponades market.
Based on the important information provided in the report regarding the challenges that new entrants face, the strategies used by leading companies in the vitreous tamponades market, and also the present and future trends, an interested individual or enterprise can effectively make smart decisions regarding investment in the market.
This 73 page report gives readers a comprehensive overview of the Vitreous Tamponades Market. Browse through 9 data tables and 15 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/vitreous-tamponades-market.html
Vitreous tamponades are used in vitrectomy procedures conducted in the human eye. These procedures assist in healing or reattachment of the retina and are also used to provide a replacement to a clouded vitreous humor. The vitreous humor of the eye acts as a refractive medium and provides nutrition to the eye. After a trauma or due to the natural process of ageing, the vitreous humor, which is a highly viscous gel-like substance made from collagen and water, starts tearing or getting detached from the fragile retina. To repair this retinal detachment and also for any other vitreoretinal disorders, vitrectomy is required. Vitrectomy involves the removal of the vitreous humor and replacing it with a synthetic substitute. This synthetic substitute is called a vitreous tamponade. Currently, the most commonly used substitutes are: silicone oil, perfluorocarbon liquids, and intraocular gases.
The global vitreous tamponade market is expected to expand due to the rising incidence of retinal detachment and growth of the geriatric population. The growing cases of diabetic retinopathy, macular pucker, and similar other retinal disorders are also driving the global vitreous tamponade market. Vitreous substitutes are biocompatible and transparent, which allow them to replace natural vitreous humor successfully.
Get accurate market forecast and analysis on the Vitreous Tamponades Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4233
The global vitreous tamponade market is segmented on the basis of type and geography. On the basis of type, the market is segmented into gaseous tamponades and liquid tamponades. Liquid tamponades are further classified into silicone oil and perfluorocarbons. Although the liquid tamponades market was the leading segment in 2013, accounting for 49% of the global market, the gaseous tamponades segment is expected to grow at a faster rate due to their ease of use and lower costs. The most extensively used gaseous tamponades in vitreoretinal surgeries are C2F8, SF6, and C3F8, as these gases are expansive and allow the eyeball and the retina to gradually adjust to the volume of the eye, enabling better healing.
Some of the key manufacturers of vitreous tamponades profiled in the report are: Valeant Pharmaceuticals International, Inc. (parent of Bausch + Lomb), Alcon, Inc., Carl Zeiss Meditec AG, Fluoron GmbH, Dutch Ophthalmic Research Center B.V., AL.CHI.MI.A Srl, and Croma Pharma AG.
Transparency Market Research
90 State Street,
NY – 12207
USA – Canada Toll Free 866-552-3453